Macrogol 3350, Anhydrous sodium sulfate, Sodium chloride, Potassium chloride, Ascorbic acid and Sodium ascorbate
Please read this leaflet carefully before taking this medicine because it contains important information for you.

Keep this leaflet. You may need to read it again.
If you have any questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not give it to others, even if their symptoms are the same as yours, as it could be harmful.
If you experience any side effects, including those not listed in this leaflet, contact your doctor or pharmacist. See section 4.

Contents of this leaflet

What Moviprep is and what it is used for
What you need to know before taking Moviprep
How to take Moviprep
Possible side effects
How to store Moviprep
Contents of the pack and other information

1. What Moviprep is and what it is used for

Moviprep is a lemon-flavoured laxative supplied in four sachets. There are two large sachets ('sachet A') and two small sachets ('sachet B'). All four are required for a single treatment.
Moviprep is used in adults to clean the bowel in preparation for an examination.
Moviprep works by emptying the bowel contents, so you should expect to have watery bowel movements.

2. What you need to know before taking Moviprep

Do not take Moviprep

if you are allergic (hypersensitive) to the active substances or to any of the other ingredients of this medicine (listed in section 6)
if you have intestinal obstruction
if you have a perforation of the intestinal wall
if you have conditions related to stomach emptying problems
if you have intestinal paralysis (usually occurring after abdominal surgery)
if you suffer from phenylketonuria. This is an inherited inability of the body to process a specific amino acid. Moviprep contains a source of phenylalanine
if your body is unable to produce sufficient amounts of glucose-6-phosphate dehydrogenase
if you have toxic megacolon (a severe complication of acute colitis)

Warnings and precautions
If you are in poor general health or have a serious medical condition, you should be particularly aware of the possible side effects listed in section 4. If in doubt, consult your doctor or pharmacist.
Consult your doctor or pharmacist before taking Moviprep if you are in any of the following situations:

you tend to regurgitate swallowed drinks or foods, or gastric acids, or if you have swallowing difficulties (see also Moviprep with food and drink)
you have kidney disorders
you suffer from heart failure, severe kidney problems, or are taking medications for blood pressure
you have heart failure or heart diseases including high blood pressure, irregular heartbeat, or palpitations
thyroid disorders
you are dehydrated
you have flare-ups of inflammatory bowel diseases (Crohn's disease or ulcerative colitis)
you suffer from epilepsy or have a history of seizures

Do not administer Moviprep without medical supervision to patients with altered consciousness.
If you experience sudden abdominal pain or rectal bleeding during Moviprep intake for bowel preparation, consult a doctor immediately.
If during Moviprep intake you experience vomiting (with blood) followed by sudden chest, neck, or abdominal pain, difficulty swallowing or breathing, stop taking the medicine and contact your doctor immediately.

Children and adolescents
Moviprep must not be taken by children and adolescents under 18 years of age.

Other medicines and Moviprep
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
If you are taking other oral medications (e.g. oral contraceptive pill), do not take them one hour before, during, or one hour after taking Moviprep, as they may be flushed through the digestive system and may not work properly.
If you are taking oral contraceptives, additional contraceptive methods (e.g. condom) may be required to prevent pregnancy.

Moviprep with food and drink
Do not eat solid foods from the time you start taking Moviprep until after the examination.
If you need to thicken liquids to swallow them safely, Moviprep may interfere with the thickening agent's effectiveness.
While taking Moviprep, you must continue to drink large amounts of fluids. The fluid content of Moviprep does not replace regular fluid intake.

Pregnancy, breastfeeding and fertility
There are no data available on the use of Moviprep during pregnancy or breastfeeding. It should be used only if considered essential by your doctor. If you are pregnant, suspect you may be pregnant, planning to become pregnant, or are breastfeeding, consult your doctor or pharmacist before taking this medicine.

Driving and using machines
Moviprep does not affect the ability to drive or operate machinery.

Moviprep contains sodium, potassium and a source of phenylalanine
This medicine contains 8.4 g of sodium (main component of table salt) per treatment cycle. (A treatment cycle involves the intake of two liters of Moviprep). This corresponds to 420% of the maximum recommended daily dietary intake for an adult. This should be taken into account in individuals on a low-sodium diet. Only a portion (up to 2.6 g per treatment cycle) of sodium is absorbed.
This medicine contains 1.1 g of potassium per treatment cycle. (A treatment cycle involves the intake of two liters of Moviprep). This should be considered in patients with impaired kidney function or in patients on a low-potassium diet.
Contains a source of phenylalanine. It may be harmful to you if you have phenylketonuria.

3. How to take Moviprep

Take this medicine exactly as directed by your doctor. If you have any doubts, consult your
doctor or pharmacist.
The recommended dose is two litres of solution, prepared as follows:
This package contains two transparent pouches, each containing two sachets: sachet A and sachet B.
Each pair of sachets (A and B) must be dissolved in water to make one litre of solution.
Therefore, this package is sufficient to prepare two litres of Moviprep solution.
Before taking Moviprep, read the following instructions carefully. You need to know:

When to take Moviprep
How to prepare Moviprep
How to drink Moviprep
What to expect

When to take Moviprep
Take this medicine exactly as described in this leaflet or as instructed by your doctor. If you have any doubts, consult your doctor. Your treatment with Moviprep must be completed before the examination.
The treatment regimen can be taken either as split doses or as a single dose, as described below:
For procedures requiring sedation (using general anaesthesia):

Split doses: one litre of Moviprep the evening before, and one litre of Moviprep early in the morning on the day of the examination. Ensure that the intake of Moviprep and all clear liquids is completed at least two hours before the start of the examination.
Single dose: two litres of Moviprep the evening before the examination, or two litres of Moviprep on the morning of the examination. Ensure that the intake of Moviprep and all clear liquids is completed at least two hours before the start of the examination.

For procedures not requiring sedation (without general anaesthesia):

Split doses: one litre of Moviprep the evening before, and one litre of Moviprep early in the morning on the day of the examination. Ensure that the intake of Moviprep and all clear liquids is completed at least one hour before the start of the examination.
Single dose: two litres of Moviprep the evening before the examination, or two litres of Moviprep on the morning of the examination. Ensure that the intake of Moviprep is completed at least two hours before the start of the examination. Ensure that the intake of all clear liquids is completed at least one hour before the start of the examination.

Important: Do not eat solid foods from the time you start taking Moviprep until after the examination.
How to prepare Moviprep

Open one transparent pouch and remove sachets A and B.
Empty the contents of sachets A and B into a graduated container with a one-litre capacity.
Add water up to the one-litre mark on the container and stir until all the powder is completely dissolved and the Moviprep solution becomes clear or slightly cloudy. This may take up to 5 minutes.

How to drink Moviprep
Drink the first litre of Moviprep solution over one to two hours. Try to drink a full glass every 10–15 minutes.
When ready, prepare and drink the second litre of Moviprep solution using the contents of sachets A and B from the second pouch.
During this treatment, you are advised to drink an additional one litre of clear liquid to prevent excessive thirst and dehydration. Water, broth, fruit juice ( without pulp ), carbonated soft drinks, tea, or coffee ( without milk ) are all suitable beverages. These drinks may be consumed up to a maximum of two hours before the clinical examination under general anaesthesia, or up to a maximum of one hour before the clinical examination without general anaesthesia.
What to expect
When you begin drinking the Moviprep solution, it is important to stay close to a toilet. At some point, you will begin to have watery bowel movements. This is completely normal and indicates that the Moviprep solution is working. Bowel movements will stop shortly after you finish drinking the solution.
If you follow these instructions, your bowel will be clean, which will help ensure the success of the examination.
After your last sip, allow sufficient time to reach the colonoscopy unit.
If you take more Moviprep than you should
If you take more Moviprep than recommended, you may experience excessive diarrhoea, which could lead to dehydration. Drink plenty of fluids, especially fruit juices. If you are concerned, contact your doctor or pharmacist.
If you forget to take Moviprep
If you forget to take Moviprep, take the missed dose as soon as you remember. If several hours have passed since the scheduled dose, consult your doctor or pharmacist. When taking Moviprep as split doses, it is important to complete the entire Moviprep solution at least one hour before the examination (without general anaesthesia) or two hours before the examination (with general anaesthesia). When taking the entire Moviprep dose on the morning of the examination as a single dose, it is important to complete the entire solution at least two hours before the examination.
If you have any questions about the use of this medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, Moviprep can cause side effects, although not everyone gets them.
It is normal to experience diarrhoea when taking Moviprep.

Stop taking Moviprep and contact your doctor immediately if you experience any of the following side effects:

skin rash or itching
swelling of the face, ankles or other parts of the body
palpitations
excessive tiredness
shortness of breath

These are symptoms of a serious allergic reaction.
Stop taking Moviprep and contact your doctor immediately if you experience any of the following side effects:

seizure

If you do not experience bowel movements within 6 hours after taking Moviprep, stop taking it and contact your doctor immediately.

Other side effects include:
Very common side effects (may affect more than 1 in 10 people): abdominal pain, abdominal distension, fatigue, feeling unwell, anal pain, nausea, and fever.
Common side effects (may affect up to 1 in 10 people): feeling hungry, sleep problems, dizziness, headache, vomiting, indigestion, thirst, and chills.
Uncommon side effects (may affect up to 1 in 100 people): discomfort, difficulty swallowing, and changes in liver function tests.

The following side effects have sometimes been reported, but their frequency is unknown because it cannot be determined from the available data: flatulence (gas), temporary increase in blood pressure, irregular heartbeat or palpitations, dehydration, retching (effort to vomit), oesophageal rupture caused by vomiting, very low plasma sodium levels which may lead to seizures (fits), and changes in blood electrolyte levels such as decreased bicarbonate, increased or decreased calcium, increased or decreased chloride, and decreased phosphate. Plasma levels of potassium and sodium may also decrease.

These reactions usually occur only during the duration of treatment. If they persist, consult your doctor.
Allergic reactions may cause skin rash, itching, redness of the skin or hives, swelling of the hands, feet or ankles, headache, palpitations and shortness of breath.

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor, pharmacist or nurse. You can also report side effects directly via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse. By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Moviprep

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton after “Exp.”. Please
note that the expiry dates of the individual sachets may differ. The expiry date refers to the last day of the month.
Store Moviprep sachets at room temperature (below 25°C).
Once Moviprep has been dissolved in water, the solution may be stored (covered) at room temperature (below 25°C).
It may also be stored in the refrigerator (2°C – 8°C). Do not store for more than 24 hours.

Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. This will help protect the environment.

6. Package contents and other information

What Moviprep contains
Pouch A contains the following active substances:
Macrogol (also known as polyethylene glycol) 3350 100 g
Anhydrous sodium sulfate 7.500 g
Sodium chloride 2.691 g
Potassium chloride 1.015 g
Pouch B contains the following active substances:
Acidum ascorbicum 4.700 g
Natrium ascorbicum 5.900 g
When the components from both pouches are mixed to prepare one litre of solution,
the electrolyte ion concentration is as follows:
Sodium 181.6 mmol/L (of which no more than 56.2 mmol are absorbable)
Chloride 59.8 mmol/L
Sulfate 52.8 mmol/L
Potassium 14.2 mmol/L
Ascorbate 56.5 mmol/L
The other components are:
Lemon flavour (containing maltodextrin, citral, lemon oil, lime oil, arabic gum, vitamin E), aspartame (E951) and acesulfame potassium (E950) as sweeteners. For further information, see section 2.
Description of the appearance of Moviprep and contents of the pack
This pack contains two transparent bags, each containing two sachets: pouch A and pouch B.
Each pair of pouches (A and B) must be dissolved in one litre of water.
Moviprep powder for oral solution is available in packs of 1, 10, 40, 80, 160 and 320 single treatment packs and hospital packs containing 40 single treatments. Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Norgine B.V., Antonio Vivaldistraat 150, 1083 HP Amsterdam, The Netherlands
Represented in Italy by
Norgine Italia S.r.l., Piazza Gae Aulenti, 1 Torre B, 20154 Milano, Italy
Manufacturer
Norgine B.V., Antonio Vivaldistraat 150, 1083 HP Amsterdam, The Netherlands
or
Meribel Pharma Höganäs AB, Sporthallsvägen 6, Höganäs, 263 35, Sweden
or
SOPHARTEX, 21 rue du Pressoir, 28500 Vernouillet, France
This medicinal product is authorised in the European Economic Area Member States under the
following names:
Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, The Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia and Spain: Moviprep
Sweden: Movprep
This leaflet was last updated on 01/2026

The following information is intended exclusively for physicians or healthcare professionals:
Moviprep must be administered with caution in frail patients or those in poor general health, or in patients with severe clinical conditions such as:

impaired gag reflex, or with risk of aspiration or regurgitation
altered state of consciousness
severe renal impairment (creatinine clearance < 30 mL/min)
severe cardiac failure (NYHA class III or IV)
patients at risk of arrhythmia, for example those being treated for cardiovascular diseases or with thyroid disorders
dehydration
acute severe inflammatory bowel disease

Any existing dehydration or electrolyte imbalances must be corrected before administering Moviprep.
Patients with reduced consciousness or at risk of aspiration or regurgitation must be closely monitored during administration, especially if administered via nasogastric tube.
Moviprep must not be administered to unconscious patients.

Package Leaflet: Information for the User

Moviprep Orange Flavour, powder for oral solution

Macrogol 3350, Anhydrous sodium sulfate, Sodium chloride, Potassium chloride, Ascorbic acid and Sodium ascorbate
Please read this leaflet carefully before taking this medicine because it contains important information for you.

Keep this leaflet. You may need to read it again.
If you have any questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not give it to others, even if their symptoms are the same as yours, because it could be harmful.
If you experience any side effects, including those not listed in this leaflet, contact your doctor or pharmacist. See section 4.

Contents of this leaflet

What Moviprep Orange is and what it is used for
What you need to know before taking Moviprep Orange
How to take Moviprep Orange
Possible side effects
How to store Moviprep Orange
Package contents and other information

1. What Moviprep Orange is and what it is used for

Moviprep Orange is an orange-flavoured laxative contained in four sachets. There are two large sachets ('sachet A') and two small sachets ('sachet B'). All four are required for one treatment.
Moviprep Orange is used in adults to cleanse the bowel in preparation for an examination.
Moviprep Orange works by emptying the bowel contents, therefore you should expect to have watery bowel movements.

2. What you need to know before taking Moviprep Orange

Do not take Moviprep Orange

if you are allergic (hypersensitive) to the active substances or to any of the other ingredients of this medicine (listed in section 6)
if you have intestinal obstruction
if you have a perforation (tear) in the intestinal wall
if you have conditions related to stomach emptying problems
if you have intestinal paralysis (usually occurring after abdominal surgery)
if you suffer from phenylketonuria. This is an inherited condition in which the body cannot properly use a particular amino acid. Moviprep Orange contains a source of phenylalanine
if your body is unable to produce sufficient amounts of glucose-6-phosphate dehydrogenase
if you have toxic megacolon (a severe complication of acute colitis)

Warnings and precautions
If you are in poor general health or have a serious medical condition, you should be particularly aware of the possible side effects listed in section 4. If in doubt, consult your doctor or pharmacist.
Consult your doctor or pharmacist before taking Moviprep Orange if you fall into any of the following categories:

you tend to regurgitate swallowed drinks or food, or gastric acids, or if you have swallowing difficulties (see also Moviprep Orange with food and drink)
you have kidney disorders
you suffer from heart failure, severe kidney problems, or are taking medications for blood pressure
you have heart failure or heart diseases including high blood pressure, irregular heartbeat, or palpitations
thyroid disorders
you are dehydrated
you have flare-ups of inflammatory bowel diseases (Crohn’s disease or ulcerative colitis)
you suffer from epilepsy or have a history of seizures

Do not administer Moviprep Orange without medical supervision to patients with altered consciousness.
If you experience sudden abdominal pain or rectal bleeding while taking Moviprep Orange for bowel preparation, contact a doctor immediately.
If vomiting (including vomiting blood) occurs during treatment with Moviprep Orange, followed by sudden chest, neck, or abdominal pain, difficulty swallowing or breathing, stop taking the medicine and contact your doctor immediately.

Children and adolescents
Moviprep Orange must not be given to children and adolescents under 18 years of age.

Other medicines and Moviprep Orange
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
If you are taking other oral medications (e.g. oral contraceptive pills), do not take them one hour before, during, or one hour after taking Moviprep Orange, as they may be flushed through the digestive system and may not work properly.
If you are taking oral contraceptives, additional contraceptive methods (e.g. condom) may be required to prevent pregnancy.

Moviprep Orange with food and drink
Do not eat solid foods from the time you start taking Moviprep Orange until after the examination.
If you need to thicken liquids to swallow them safely, Moviprep Orange may interfere with the thickening agent’s effectiveness.
While taking Moviprep Orange, you must continue to drink large amounts of fluids. The fluid content of Moviprep Orange does not replace regular fluid intake.

Pregnancy, breastfeeding and fertility
There are no data available on the use of Moviprep Orange during pregnancy or breastfeeding. It should be used only if considered essential by your doctor. If you are pregnant, suspect you may be pregnant, are planning to become pregnant, or are breastfeeding, consult your doctor or pharmacist before taking this medicine.

Driving and using machines
Moviprep Orange does not affect the ability to drive or operate machinery.

Moviprep Orange contains sodium, potassium and a source of phenylalanine
This medicine contains 8.4 g of sodium (main component of table salt) per treatment cycle. (A treatment cycle involves the intake of two litres of Moviprep Orange.) This corresponds to 420% of the maximum recommended daily dietary intake for an adult. This should be taken into consideration in patients on a low-sodium diet. Only a portion (up to 2.6 g per treatment cycle) of sodium is absorbed.
This medicine contains 1.1 g of potassium per treatment cycle. (A treatment cycle involves the intake of two litres of Moviprep Orange.) This should be taken into consideration in patients with reduced kidney function or those on a low-potassium diet.
Contains a source of phenylalanine. It may be harmful if you have phenylketonuria.
If your doctor has diagnosed you with an intolerance to certain sugars, contact him/her before taking this medicine.

3. How to take Moviprep Orange

Take this medicine exactly as directed by your doctor. If you have any doubts, consult your
doctor or pharmacist.
The recommended dose is two litres of solution, prepared as follows:
This pack contains two transparent pouches, each containing two sachets: sachet A and sachet B.
Each pair of sachets (A and B) must be dissolved in water to make up one litre of solution.
Therefore, this pack is sufficient to prepare two litres of Moviprep Orange solution.
Before taking Moviprep Orange, read the following instructions carefully. You need to know:

When to take Moviprep Orange
How to prepare Moviprep Orange
How to drink Moviprep Orange
What to expect

When to take Moviprep Orange
Take this medicine exactly as described in this leaflet or as instructed by your doctor. If you have any
doubts, consult your doctor. Your treatment with Moviprep Orange must be completed before the
examination.
The treatment regimen may be taken either as split doses or as a single dose, as described below:
For procedures requiring sedation (using general anaesthesia):

Split doses: one litre of Moviprep Orange the evening before the examination and one litre of Moviprep Orange early in the morning on the day of the examination. Make sure that the intake of Moviprep Orange and all clear liquids is completed at least two hours before the start of the examination.
Single dose: two litres of Moviprep Orange the evening before the examination or two litres of Moviprep Orange on the morning of the examination. Make sure that the intake of Moviprep Orange and all clear liquids is completed at least two hours before the start of the examination.

For procedures not requiring sedation (without general anaesthesia):

Split doses: one litre of Moviprep Orange the evening before the examination and one litre of Moviprep Orange early in the morning on the day of the examination. Make sure that the intake of Moviprep Orange and all clear liquids is completed at least one hour before the start of the examination.
Single dose: two litres of Moviprep Orange the evening before the examination or two litres of Moviprep Orange on the morning of the examination. Make sure that the intake of Moviprep Orange is completed at least two hours before the start of the examination. Ensure that the intake of all clear liquids is completed at least one hour before the start of the examination.

Important: Do not eat solid foods from the time you start taking Moviprep Orange until after the examination.
How to prepare Moviprep Orange

Open one transparent pouch and remove sachets A and B.
Empty the contents of sachets A and B into a graduated 1-litre container.
Add water up to the 1-litre mark on the container and stir until all the powder is completely dissolved and the Moviprep Orange solution becomes clear or slightly cloudy. This may take up to 5 minutes.

How to drink Moviprep Orange
Drink the first litre of Moviprep Orange solution within one to two hours. Try to drink a full glass every 10–15 minutes.
When ready, prepare and drink the second litre of Moviprep Orange solution using the contents of sachets A and B from the second pouch.
During this treatment, you are advised to drink an additional litre of clear liquid to help prevent excessive thirst and dehydration. Water, broth, fruit juice ( without pulp ), carbonated soft drinks, tea, or coffee ( without milk ) are all suitable beverages. These drinks may be consumed up to a maximum of two hours before the clinical examination performed under general anaesthesia, or up to a maximum of one hour before the clinical examination performed without general anaesthesia.
What to expect
When you start drinking the Moviprep Orange solution, it is important to stay close to a toilet. Eventually, you will begin to pass watery stools. This is completely normal and indicates that the Moviprep Orange solution is working. Bowel movements will stop shortly after you finish drinking the solution.
If you follow these instructions, your bowel will be clean, which will help ensure the examination is performed successfully.
After your last sip, allow sufficient time to reach the colonoscopy unit.
If you take more Moviprep Orange than you should
If you take more Moviprep Orange than recommended, you may experience excessive diarrhoea, which could lead to dehydration. Drink plenty of fluids, especially fruit juices. If you are concerned, contact your doctor or pharmacist.
If you forget to take Moviprep Orange
If you forget to take Moviprep Orange, take the missed dose as soon as you remember. If several hours have passed since the scheduled time, consult your doctor or pharmacist. When taking Moviprep Orange as split doses, it is important to complete the entire Moviprep Orange solution at least one hour before the examination (without general anaesthesia) or two hours before the examination (with general anaesthesia). When taking all of Moviprep Orange on the morning of the examination as a single dose, it is important to complete the entire Moviprep Orange solution at least two hours before the examination.
If you have any questions about the use of this medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, Moviprep Orange may cause side effects, although not everyone gets them.
It is normal to have diarrhoea when taking Moviprep Orange.
Stop taking it and contact your doctor immediately if you experience any of the following side effects:

skin rash or itching
swelling of the face, ankles or other parts of the body
palpitations
excessive tiredness
shortness of breath

These are symptoms of a severe allergic reaction.
Stop taking Moviprep Orange and contact your doctor immediately if you experience any of the following side effects:

seizure

If you do not have a bowel movement within 6 hours of taking Moviprep Orange, stop taking it and contact your doctor immediately.
Other side effects include:
Very common side effects (may affect more than 1 in 10 people): abdominal pain, abdominal distension, fatigue, feeling unwell, anal pain, nausea, and fever.
Common side effects (may affect up to 1 in 10 people): feeling of hunger, sleep disturbances, dizziness, headache, vomiting, indigestion, thirst, and chills.
Uncommon side effects (may affect up to 1 in 100 people): discomfort, difficulty swallowing, and changes in liver function tests.
The following side effects have sometimes been reported, but their frequency is unknown because it cannot be estimated from the available data: flatulence (gas), temporary increase in blood pressure, irregular heartbeat or palpitations, dehydration, retching (effort to vomit), oesophageal rupture caused by vomiting, very low plasma sodium levels which may lead to seizures (fits), and changes in blood electrolyte levels such as decreased bicarbonate, increased or decreased calcium, increased or decreased chloride, and decreased phosphate. Plasma levels of potassium and sodium may also decrease.
These reactions usually occur only for the duration of treatment. If they persist, consult your doctor.
Allergic reactions may cause skin rash, itching, redness of the skin or hives, swelling of hands, feet or ankles, headache, palpitations, and shortness of breath.

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor, pharmacist, or nurse. You can also report side effects directly via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse. By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Moviprep Orange

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton after "Exp.". Please
note that the expiry dates of the individual sachets may differ. The expiry date refers to the last day of the month.
Store Moviprep Orange sachets at room temperature (below 25°C).
Once Moviprep Orange has been dissolved in water, the solution may be stored (kept covered) at room temperature (below 25°C). It may also be stored in the refrigerator (2°C - 8°C). Do not store for more than 24 hours.
Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Package contents and other information

What Moviprep Orange contains
Pouch A contains the following active ingredients:
Macrogol (also known as polyethylene glycol) 3350 100 g
Anhydrous sodium sulfate 7.500 g
Sodium chloride 2.691 g
Potassium chloride 1.015 g
Pouch B contains the following active ingredients:
Ascorbic acid 4.700 g
Sodium ascorbate 5.900 g

When the contents of the two pouches are mixed to prepare one litre of solution, the electrolyte ion concentration is as follows:
Sodium 181.6 mmol/L (of which no more than 56.2 mmol are absorbable)
Chloride 59.8 mmol/L
Sulfate 52.8 mmol/L
Potassium 14.2 mmol/L
Ascorbate 56.5 mmol/L

The other components are:
Orange flavour (containing natural flavouring substances and preparations, maltodextrin, dextrose),
aspartame (E951) and acesulfame potassium (E950) as sweeteners. For further information, see section 2.

Description of the appearance of Moviprep Orange and contents of the pack
This package contains two transparent bags, each containing two pouches: pouch A and pouch B.
Each pair of pouches (A and B) must be dissolved in one litre of water.
Moviprep Orange flavour oral powder for solution is available in packs containing 1, 10, 40, 80, 160 and 320 single treatment packs, and a hospital pack containing 40 single treatments. Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Norgine B.V., Antonio Vivaldistraat 150, 1083 HP Amsterdam, The Netherlands
Represented in Italy by
Norgine Italia S.r.l., Piazza Gae Aulenti, 1 Torre B, 20154 Milano, Italy
Manufacturer
SOPHARTEX, 21 rue du Pressoir, 28500 Vernouillet, France
or
Norgine B.V., Antonio Vivaldistraat 150, 1083 HP Amsterdam, The Netherlands

This medicinal product is authorised in the Member States of the European Economic Area under the following names:
Member State Medicinal Product
Austria MOVIPREP Orange
Belgium MOVIPREP Sinaas/Orange
Denmark MOVIPREP Appelsin
Finland MOVIPREP Appelsiini
France MOVIPREP Orange
Germany MOVIPREP Orange
Ireland MOVIPREP Orange
Italy MOVIPREP Orange flavour
Luxembourg MOVIPREP Sinaas/Orange
The Netherlands MOVIPREP Orange
Spain MOVIPREP Orange flavour
Sweden MOVIPREP APELSIN

This leaflet was last updated on 01/2026

The following information is intended exclusively for physicians or healthcare professionals:
Moviprep Orange must be administered with caution in frail patients with poor general health or in patients with severe clinical conditions such as:

impaired pharyngeal reflex, or with risk of aspiration or regurgitation
altered state of consciousness
severe renal impairment (creatinine clearance < 30 mL/min)
heart failure (NYHA class III or IV)
patients at risk of arrhythmia, for example those receiving treatment for cardiovascular diseases or with thyroid disorders
dehydration
acute severe inflammatory bowel disease

Any existing dehydration or electrolyte imbalances must be corrected prior to administration of Moviprep Orange.
Patients with reduced consciousness or at risk of aspiration or regurgitation must be closely monitored during administration, particularly if administered via nasogastric route.
Moviprep Orange must not be administered to unconscious patients.